公开(公告)号：US20050008574A1

公开(公告)日：2005-01-13

申请号：US10851213

申请日：2004-05-24

申请人： Ulrich Speck ,  Irtel Von Brenndorff

发明人： Ulrich Speck ,  Irtel Von Brenndorff

IPC分类号： A61B6/00 ,  A61K49/00 ,  A61K49/04 ,  A61K49/06 ,  A61P35/04 ,  G06T5/00 ,  G06T5/50

CPC分类号： A61K49/0409 ,  A61K49/0457

摘要： The invention relates to the use of intravenous contrast media for projection mammography as well as new devices for projection mammography. The invention therefore relates to the use of intravenous contrast media for the production of a diagnostic agent for projection mammography. Through the additional intravenous administration of contrast media, projection mammography achieves a sensitivity that is comparable to that of the most modern processes such as magnetic resonance tomography (MRT) while being considerably more versatile and avoiding the costs of MRT. The new process can be implemented simply and without special stress on the patients and provides a significant improvement in a) sensitivity to the detection of focal lesions in the breast, and b) additional information on the nature of lesions detected previously.

摘要翻译： 本发明涉及用于投影乳房X线照相术的静脉造影剂的使用以及用于投影乳房X线照相术的新装置。 因此，本发明涉及静脉造影剂用于生产用于投影乳房X线照相术的诊断剂的用途。 通过额外静脉注射造影剂，投影乳房X线照相术的灵敏度可以达到最现代的方法，如磁共振断层扫描（MRT）的灵敏度，同时具有更大的灵活性，避免了MRT的成本。 新过程可以简单实现，对患者没有特别的压力，并且对a）对乳房局灶性病变检测的敏感度以及b）关于先前检测到的病变性质的额外信息提供了显着的改善。